Review Article Now Published in the British Journal of Clinical Pharmacology Finds Widely Sold Non-Prescription CBD Products at Doses ...
Adults with ADHD and comorbid anxiety experienced improvements in both with centanafadine, according to a press release from ...
The U.S. House of Representatives on Tuesday voted to make daylight saving time (DST) year-round. If the Sunshine Protection ...
Families caring for loved ones with advanced dementia and severe agitation now have a new piece of clinical evidence to weigh ...
An experimental treatment combining THC and CBD significantly reduced agitation in people with late-stage Alzheimer's disease ...
From the best portable fan to magnesium supplements and clever mattress-coolers, these products will help you sleep through ...
In the phase 2 LiBBY trial presented, tetrahydrocannabinol and cannabidiol reduced agitation scores and improved clinician-rated outcomes in patients with advanced dementia.
Cannabidiol (CBD) is a naturally occurring compound found in cannabis. Unlike THC, it is not intoxicating and does not ...
The results mark a major step in dementia treatment, especially as more than 7 million Americans currently have Alzheimer’s, ...
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of ...
Summer is peak season for outdoor recreation, and in Colorado, that often means bringing dogs along for the adventure. But ...